Electrochemical behavior of disopyramide and its adsorptive stripping determination in pharmaceutical dosage forms and biological fluids
- 17 June 2010
- journal article
- Published by Institute of Organic Chemistry & Biochemistry in Collection of Czechoslovak Chemical Communications
- Vol. 75 (6) , 685-702
Abstract
Electrochemical behavior of disopyramide (DPA) and optimum conditions to its quantitative determination were investigated using voltammetric methods. Some electrochemical parameters such as diffusion coefficient, surface coverage of adsorbed molecules, electron transfer coefficient, standard rate constant and number of electrons were calculated using the results of cyclic and square-wave voltammetry. All studies were based on the quasi-reversible and adsorption-controlled electrochemical reduction signal of DPA at about –1.60 V vs Ag|AgCl at pH 10.0 in Britton–Robinson buffer. This adsorptive character of molecule was used to develop fully validated, new, rapid, selective and simple square-wave cathodic adsorptive stripping voltammetric (SWCAdSV) method to the direct determination of DPA in pharmaceutical dosage forms and biological samples without time-consuming steps prior to drug assay. Peak current of electrochemical reduction of DPA was found to change linearly with the concentration in the range from 7.15 × 10–8 mol l–1 (0.024 mg l–1) to 1.43 × 10–6 mol l–1 (0.49 mg l–1). Limit of detection (LOD) and limit of quantification (LOQ) were found to be 5.65 × 10–8 mol l–1 (0.019 mg l–1) and 1.88 × 10–7 mol l–1 (0.064 mg l–1), respectively. The method was successfully applied to assay the drug in tablets, human serum and human urine with good recoveries at about 100%.Keywords
This publication has 30 references indexed in Scilit:
- Extractive-spectrophotometric determination of disopyramide and irbesartan in their pharmaceutical formulationSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2007
- Enantioselective analysis of disopyramide and mono-N-dealkyldisopyramide in plasma and urine by high-performance liquid chromatography on an amylose-derived chiral stationary phaseJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Quantitative determination of disopyramide, verapamil and flecainide enantiomers in rat plasma and tissues by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Determination of disopyramide in plasma by high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1994
- Simplified, rapid and inexpensive extraction procedure for a high-performance liquid chromatographic method for determination of disopyramide and its main metabolite mono-N-dealkylated disopyramide in serumJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- Direct enantiomeric resolution of disopyramide and its metabolite using chiral high-performance liquid chromatography : Application to stereoselective metabolism and pharmacokinetics of racemic disopyramide in manJournal of Chromatography A, 1988
- Simultaneous assay of disopyramide and monodesisopropyldisopyramide enantiomers in biological samples by liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Use of Silica Gel with Aqueous Eluent for Simultaneous High Performance Liquid Chromatographic Assay of Disopyramide and Mono-N-DealkyldisopyramideTherapeutic Drug Monitoring, 1986
- Simultaneous high-performance liquid chromatographic assay for quinidine, disopyramide and the mono-N-dealkylated metabolite of disopyramideJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Simultaneous analysis of disopyramide and quinidine in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980